CMIDX | RPMGX | CMIDX / RPMGX | |
Total Expense Ratio | 1.05 | 0.75 | 140% |
Annual Report Gross Expense Ratio | 1.05 | 0.75 | 140% |
Fund Existence | 13 years | 33 years | - |
Gain YTD | 1.734 | 2.537 | 68% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 2500 | 80% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 687M | 26.7B | 3% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | -10.88 | -5.53 | 197% |
Returns for 3 years | 0.54 | 19.23 | 3% |
Returns for 5 years | -13.87 | -4.29 | 323% |
Returns for 10 years | 52.79 | 28.82 | 183% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBP | 72.16 | 0.53 | +0.75% |
Virtus LifeSci Biotech Products ETF | |||
JCPB | 47.45 | 0.04 | +0.08% |
JPMorgan Core Plus Bond ETF | |||
KCE | 151.18 | 0.10 | +0.07% |
SPDR® S&P Capital Markets ETF | |||
IBDZ | 26.44 | -0.01 | -0.04% |
iShares iBonds Dec 2034 Term Corp ETF | |||
SCJ | 90.90 | -0.53 | -0.58% |
iShares MSCI Japan Small-Cap ETF |